BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37955647)

  • 1. The impact of submandibular glands protection on xerostomia as monitored by diffusion-weighted imaging in nasopharyngeal carcinoma patients.
    Zhao D; Fan W; Jiang H; Meng L; Cai B; Zhang X; Yu W; Zhao L; Ma L
    Strahlenther Onkol; 2024 May; 200(5):377-388. PubMed ID: 37955647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Diffusion Kurtosis Imaging in Evaluating Acute Xerostomia in Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy.
    Zhao DW; Fang XM; Zhou SH; Luo YR; Wei J; Liu K; Meng LL; Liu G; Li JF; Zang X; Li M; Qiang XF; Jiang HY; Fan WJ; Zhang XX; Ma L
    Front Oncol; 2022; 12():870315. PubMed ID: 35664750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sparing submandibular gland to alleviating acute xerostomia in patients with nasopharyngeal carcinoma treated with helical tomotherapy: Evaluation by diffusion kurtosis imaging.
    Zhao DW; Fan WJ; Fang XM; Luo YR; Wei J; Chen NX; Zhang XX; Liu G; Li JF; Zang X; Li M; Meng L; Ma L
    Radiother Oncol; 2022 Jul; 172():91-98. PubMed ID: 35584742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study.
    Fan WJ; Teng F; Luo YR; Yu W; Zhang Q; Lu YP; Ma L
    Strahlenther Onkol; 2020 Jun; 196(6):530-541. PubMed ID: 32025803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion weighted imaging in submandibular gland sparing helical tomotherapy for nasopharyngeal carcinoma.
    Fan WJ; Teng F; Liu G; Zhao DW; Li JF; Luo YR; Zhang XX; Ma L; Guan J
    Radiother Oncol; 2021 Apr; 157():247-254. PubMed ID: 33587972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.
    Little M; Schipper M; Feng FY; Vineberg K; Cornwall C; Murdoch-Kinch CA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1007-14. PubMed ID: 22056067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of protective effects on salivary and swallowing structures and improvement of late xerostomia and dysphagia by level IIb optimisation in clinical target volume of nasopharyngeal carcinoma.
    Zhou J; Wang L; Qiu T; Gao H; Wang L; Huang S; He X; Wu L
    BMC Cancer; 2024 May; 24(1):648. PubMed ID: 38802747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Parotid Glands on an Energy Spectrum CT Iodine Map to Evaluate Irradiation-Induced Acute Xerostomia in Patients With Nasopharyngeal Carcinoma.
    Chen R; Xie J; Chen J; Li X; Lin Q; Xu Q; Chen Y; Wang L; Zheng R; Xu B
    Technol Cancer Res Treat; 2024; 23():15330338241256814. PubMed ID: 38773777
    [No Abstract]   [Full Text] [Related]  

  • 9. Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation.
    Shi D; Qian JJ; Fan GH; Shen JK; Tian Y; Xu L
    BMC Oral Health; 2019 Dec; 19(1):288. PubMed ID: 31864328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Salivary Gland Function Using Diffusion-Weighted Magnetic Resonance Imaging for Follow-Up of Radiation-Induced Xerostomia.
    Zhang Y; Ou D; Gu Y; He X; Peng W
    Korean J Radiol; 2018; 19(4):758-766. PubMed ID: 29962882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): A prospective phase II randomized controlled study.
    Huang H; Miao J; Xiao X; Hu J; Zhang G; Peng Y; Lu S; Liang Y; Huang S; Han F; Deng X; Zhao C; Wang L
    Radiother Oncol; 2022 Oct; 175():1-9. PubMed ID: 35817320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Changes in Apparent Diffusion Coefficient for Salivary Glands during Radiotherapy for Nasopharyngeal Carcinoma Associated with Xerostomia.
    Zhang Q; Wei YM; Qi YG; Li BS
    Korean J Radiol; 2018; 19(2):328-333. PubMed ID: 29520191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation-induced Xerostomia is Related to Stem Cell Dose-dependent Reduction of Saliva Production.
    van Rijn-Dekker MI; la Bastide-van Gemert S; Stokman MA; Vissink A; Coppes RP; Langendijk JA; van Luijk P; Steenbakkers RJHM
    Int J Radiat Oncol Biol Phys; 2024 Apr; ():. PubMed ID: 38631537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of parotid gland function following intensity modulated radiation therapy for head and neck cancer.
    Lee SH; Kim TH; Kim JY; Park SY; Pyo HR; Shin KH; Kim DY; Kim JY; Cho KH
    Cancer Res Treat; 2006 Apr; 38(2):84-91. PubMed ID: 19771265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.
    Eisbruch A; Kim HM; Terrell JE; Marsh LH; Dawson LA; Ship JA
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):695-704. PubMed ID: 11395238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a nomogram for prediction of recovery from moderate-severe xerostomia post-radiotherapy in nasopharyngeal carcinoma patients.
    Zhao DW; Teng F; Meng LL; Fan WJ; Luo YR; Jiang HY; Chen NX; Zhang XX; Yu W; Cai BN; Zhao LJ; Wang PG; Ma L
    Radiother Oncol; 2023 Jul; 184():109683. PubMed ID: 37120102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.
    Lin A; Kim HM; Terrell JE; Dawson LA; Ship JA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):61-70. PubMed ID: 12909216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance between hyposalivation and xerostomia among community-dwelling older adults in Japan.
    Morita I; Morioka H; Abe Y; Nomura T; Nakashima S; Sugiura I; Inagawa Y; Kondo Y; Kameyama C; Kondo K; Kobayashi N
    PLoS One; 2023; 18(3):e0282740. PubMed ID: 36867629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of life.
    Hawkins PG; Lee JY; Mao Y; Li P; Green M; Worden FP; Swiecicki PL; Mierzwa ML; Spector ME; Schipper MJ; Eisbruch A
    Radiother Oncol; 2018 Jan; 126(1):68-74. PubMed ID: 28823405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early evaluation of irradiated parotid glands with intravoxel incoherent motion MR imaging: correlation with dynamic contrast-enhanced MR imaging.
    Zhou N; Chu C; Dou X; Li M; Liu S; Zhu L; Liu B; Guo T; Chen W; He J; Yan J; Zhou Z; Yang X; Liu T
    BMC Cancer; 2016 Nov; 16(1):865. PubMed ID: 27821130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.